DUVNF yields 1548.59% · PFE yields 6.13%● Live data
📍 DUVNF pulled ahead of the other in Year 1
Combined, DUVNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DUVNF + PFE for your $10,000?
Peruvian Metals Corp. engages in the acquisition, exploration for, and development of precious and base metals in Peru. The company holds 100% interests in the Panteria Porphyry Gold - Copper Project that consists of 4 mineral concessions covering an area of 2,000 hectares in south-central Peru; and the Cerro La Cumbre project consists of 2 mineral concessions covering an area of 727 hectares. It also has interests in the Huachocolpa properties that consist of 78 contiguous and non-contiguous mining concessions covering an area of 2,548 hectares located in the Department of Huancavelica; and the Palta Dorada property, which covers an area of 1,200 hectares located in the Ancash Mining Department in northern Peru; the Indio Inka property, which covers an area of 470 hectares located in asphalted road from the Aguila Norte processing plant; and the Minas Yanayco, which covers an area of 500 hectares located in Ancash Department near the small town of Pueblo Libre, as well as the Minas Visca project in northern Peru that covers an area of approximately 94 hectares. The company was formerly known as Duran Ventures Inc. and changed its name to Peruvian Metals Corp. in September 2018. Peruvian Metals Corp. was incorporated in 1997 and is based in Edmonton, Canada.
Full DUVNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.